About the Center of Excellence Program

The "Center of Excellence for Individualization of Therapy for Breast Cancer" is a collaborative research project with Indiana University, the Hoosier Oncology Group LLC, a Walther Cancer Institute subsidiary, and research centers in the United States, Canada and Peru. The project is funded by the Department of Defense Breast Cancer Research Program of the Office of Congressionally Directed Medical Research Programs.

Combining emerging technologies with existing ones, the project will study how to match the right patient to the right drug for women with advanced breast cancer. George Sledge Jr. MD, a clinical investigator from Indiana University, will oversee the project. According to Dr. Sledge, standard treatments for advanced breast cancer are often plagued by drug failure and toxicity.

"The tragedy of modern therapy is not just its toxicity; rather, it is that so many experience so much toxicity for so little benefit." Through individualized treatment Dr. Sledge and the other researchers hope to increase effectiveness and lessen toxicity of treatment for women with advanced breast cancer.

Center of Excellence News Release